All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
EW / Edwards Lifesciences Corporation
|
|
|
|
|
|
|
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
|
|
|
|
|
LUNG / Pulmonx Corporation
|
|
|
|
|
|
|
|
NARI / Inari Medical, Inc.
|
|
|
|
|
|
|
|
AVTR / Avantor, Inc.
|
|
|
|
|
|
|
|
GMED / Globus Medical, Inc.
|
|
|
|
|
|
|
|
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ERAS / Erasca, Inc.
|
|
|
|
|
|
|
|
BIOA / BioAge Labs, Inc.
|
|
|
|
|
|
|
|
INBX / Inhibrx Biosciences, Inc.
|
|
|
|
|
|
|
|
MTSR / Metsera, Inc.
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
EWTX / Edgewise Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
SLNO / Soleno Therapeutics, Inc.
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
SLNO / Soleno Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
IMNM / Immunome, Inc.
|
|
|
|
|
|
|
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
PHVS / Pharvaris N.V.
|
|
|
|
|
|
|
|
AVBP / ArriVent BioPharma, Inc.
|
|
|
|
|
|
|
|
IRON / Disc Medicine, Inc.
|
|
|
|
|
|
|
|
RCUS / Arcus Biosciences, Inc.
|
|
|
|
|
|
|
|
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
BSX / Boston Scientific Corporation
|
|
|
|
|
|
|
|
RAPP / Rapport Therapeutics, Inc.
|
|
|
|
|
|
|
|
ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
BDX / Becton, Dickinson and Company
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
JANX / Janux Therapeutics, Inc.
|
|
|
|
|
|
|
|
ICUI / ICU Medical, Inc.
|
|
|
|
|
|
|
|
EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
QQQ / Invesco QQQ Trust, Series 1 Put
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
SYK / Stryker Corporation
|
|
|
|
|
|
|
|
SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
IWM / iShares Trust - iShares Russell 2000 ETF Put
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc. Call
|
|
|
|
|
|
|
|
YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
LLY / Eli Lilly and Company
|
|
|
|
|
|
|
|
ELVN / Enliven Therapeutics, Inc.
|
|
|
|
|
|
|
|
VIR / Vir Biotechnology, Inc.
|
|
|
|
|
|
|
|
PRAX / Praxis Precision Medicines, Inc.
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
KROS / Keros Therapeutics, Inc.
|
|
|
|
|
|
|
|
DHR / Danaher Corporation
|
|
|
|
|
|
|
|
BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
BBIO / BridgeBio Pharma, Inc.
|
|
|
|
|
|
|
|
DYN / Dyne Therapeutics, Inc.
|
|
|
|
|
|
|
|
JAZZ / Jazz Pharmaceuticals plc
|
|
|
|
|
|
|
|
ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
ROIV / Roivant Sciences Ltd.
|
|
|
|
|
|
|
|
IKNA / Ikena Oncology, Inc.
|
|
|
|
|
|
|
|
NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
AVTE / Aerovate Therapeutics, Inc.
|
|
|
|
|
|
|
|
MDT / Medtronic plc
|
|
|
|
|
|
|
|
ISRG / Intuitive Surgical, Inc.
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
INZY / Inozyme Pharma, Inc.
|
|
|
|
|
|
|
|
DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
EWTX / Edgewise Therapeutics, Inc.
|
|
|
|
|
|
|
|
NXTC / NextCure, Inc.
|
|
|
|
|
|
|
|